Pi Health Clinical Research secures £50k for AI-driven trial platform

An estimated £50k has been raised by Pi Health Clinical Research Ltd to support its work as an AI-powered clinical research organization. This investment places the Guildford-based company at an estimated post-money valuation of £65k.

The business provides an end-to-end platform called FICS alongside outsourced services used to manage and accelerate clinical trials. This technology-driven model is designed to streamline drug development for a range of clients, including life science companies, pharmaceutical firms, and clinical sites.

Incorporated in July 2025, the startup focuses its efforts on the research and experimental development of biotechnology, particularly for oncology centers. Formal documentation for this capital increase was filed and the shares allotted in June.